Cargando…

Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding

OBJECTIVES: To clarify characteristic angiographic features and clinical efficacy of selective transarterial embolization (TAE) of retained placenta with abnormal vaginal bleeding. METHODS: The study cohort comprised 22 patients (mean age, 33.5 years; range, 22–24 years) who underwent selective TAE...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaji, Ryo, Kiyosue, Hiro, Maruno, Miyuki, Hongo, Norio, Shimada, Ryuichi, Ide, Satomi, Tokuyama, Kohei, Okamoto, Mamiko, Kawano, Yasushi, Asayama, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563979/
https://www.ncbi.nlm.nih.gov/pubmed/34727271
http://dx.doi.org/10.1186/s42155-021-00265-z
_version_ 1784593517250609152
author Takaji, Ryo
Kiyosue, Hiro
Maruno, Miyuki
Hongo, Norio
Shimada, Ryuichi
Ide, Satomi
Tokuyama, Kohei
Okamoto, Mamiko
Kawano, Yasushi
Asayama, Yoshiki
author_facet Takaji, Ryo
Kiyosue, Hiro
Maruno, Miyuki
Hongo, Norio
Shimada, Ryuichi
Ide, Satomi
Tokuyama, Kohei
Okamoto, Mamiko
Kawano, Yasushi
Asayama, Yoshiki
author_sort Takaji, Ryo
collection PubMed
description OBJECTIVES: To clarify characteristic angiographic features and clinical efficacy of selective transarterial embolization (TAE) of retained placenta with abnormal vaginal bleeding. METHODS: The study cohort comprised 22 patients (mean age, 33.5 years; range, 22–24 years) who underwent selective TAE for retained placenta with abnormal bleeding between January 2018 and December 2020 at our institution. Angiographic images were reviewed by two certified radiologists with consensus. Medical records were reviewed to evaluate the efficacy of TAE. Angiographic features of retained placenta, technical success (disappearance of abnormal findings on angiography), complications, clinical outcomes (hemostatic effects and recurrent bleeding) were evaluated. RESULTS: Pelvic angiography showed a dilated vascular channel mimicking arteriovenous fistulas or an aneurysm contiguous with dilated uterine arteries in the mid-arterial–capillary phase in 20 patients; it showed contrast brush in the remaining two patients. TAE technical success was achieved in all patients. No major complications were observed in any patients. Fifteen patients were followed up with expectant management after TAE; all but one patient showed no re-bleeding during the follow-up period (mean follow-up interval, 3.4 months; range, 1–17 months). One patient showed minor rebleeding, which resolved spontaneously. Seven patients underwent scheduled hysteroscopic resection within 1 week after TAE, and no excessive bleeding was observed during or after the surgical procedure in all seven patients. CONCLUSIONS: The characteristic angiographic feature of retained placenta is “dilated vascular channel that mimic low flow AVM.” TAE is a safe and effective treatment to manage retained placenta with abnormal bleeding.
format Online
Article
Text
id pubmed-8563979
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85639792021-11-15 Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding Takaji, Ryo Kiyosue, Hiro Maruno, Miyuki Hongo, Norio Shimada, Ryuichi Ide, Satomi Tokuyama, Kohei Okamoto, Mamiko Kawano, Yasushi Asayama, Yoshiki CVIR Endovasc Original Article OBJECTIVES: To clarify characteristic angiographic features and clinical efficacy of selective transarterial embolization (TAE) of retained placenta with abnormal vaginal bleeding. METHODS: The study cohort comprised 22 patients (mean age, 33.5 years; range, 22–24 years) who underwent selective TAE for retained placenta with abnormal bleeding between January 2018 and December 2020 at our institution. Angiographic images were reviewed by two certified radiologists with consensus. Medical records were reviewed to evaluate the efficacy of TAE. Angiographic features of retained placenta, technical success (disappearance of abnormal findings on angiography), complications, clinical outcomes (hemostatic effects and recurrent bleeding) were evaluated. RESULTS: Pelvic angiography showed a dilated vascular channel mimicking arteriovenous fistulas or an aneurysm contiguous with dilated uterine arteries in the mid-arterial–capillary phase in 20 patients; it showed contrast brush in the remaining two patients. TAE technical success was achieved in all patients. No major complications were observed in any patients. Fifteen patients were followed up with expectant management after TAE; all but one patient showed no re-bleeding during the follow-up period (mean follow-up interval, 3.4 months; range, 1–17 months). One patient showed minor rebleeding, which resolved spontaneously. Seven patients underwent scheduled hysteroscopic resection within 1 week after TAE, and no excessive bleeding was observed during or after the surgical procedure in all seven patients. CONCLUSIONS: The characteristic angiographic feature of retained placenta is “dilated vascular channel that mimic low flow AVM.” TAE is a safe and effective treatment to manage retained placenta with abnormal bleeding. Springer International Publishing 2021-11-02 /pmc/articles/PMC8563979/ /pubmed/34727271 http://dx.doi.org/10.1186/s42155-021-00265-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Takaji, Ryo
Kiyosue, Hiro
Maruno, Miyuki
Hongo, Norio
Shimada, Ryuichi
Ide, Satomi
Tokuyama, Kohei
Okamoto, Mamiko
Kawano, Yasushi
Asayama, Yoshiki
Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
title Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
title_full Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
title_fullStr Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
title_full_unstemmed Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
title_short Angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
title_sort angiographic features and transarterial embolization of retained placenta with abnormal vaginal bleeding
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563979/
https://www.ncbi.nlm.nih.gov/pubmed/34727271
http://dx.doi.org/10.1186/s42155-021-00265-z
work_keys_str_mv AT takajiryo angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT kiyosuehiro angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT marunomiyuki angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT hongonorio angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT shimadaryuichi angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT idesatomi angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT tokuyamakohei angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT okamotomamiko angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT kawanoyasushi angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding
AT asayamayoshiki angiographicfeaturesandtransarterialembolizationofretainedplacentawithabnormalvaginalbleeding